Cargando…
A phase I study of combination chemotherapy with gemcitabine and oral UFT for advanced non-small cell lung cancer
A phase I study was carried out to determine the optimal dose and administration schedule for combined UFT plus gemcitabine therapy in patients with non-small cell lung cancer. Twenty-four patients (including 11 patients previously treated with cisplatin as the key drug) received oral UFT 400 mg m(−...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2002
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375416/ https://www.ncbi.nlm.nih.gov/pubmed/12087453 http://dx.doi.org/10.1038/sj.bjc.6600337 |